diagnosis and treatment of infertility, first/second/third generation IVF (including
egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
disease
diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
clinical
technology applications. Many of these technologies are at the leading level both domestically
and
internationally.
Polycystic ovary is common, but its manifestations are quite different: some people just have menstrual disorder, others have acne, weight problems or long-term infertility. In this paper, the standard diagnostic process is used to sort out the evaluation and pregnancy preparation path of polycystic ovary, and the common treatment techniques and risk points are explained.

I. Definition: What is Polycystic Ovary (PCOS)?
"Polycystic ovary" usually refers to polycystic ovary syndrome (PCOS) in medicine, which is a syndrome related to ovulation function, androgen level and ovarian morphology. It is not a disease that can be "diagnosed" by a single index, but a combination of manifestations.
Diagnostic core (commonly used Rotterdam standard): Any two of the following three items can be considered (and other diseases leading to similar manifestations should be excluded):
Sporadic ovulation/anovulation (such as sporadic menstruation)
The manifestations or laboratory tests of hyperandrogenism suggest hyperandrogenism.
Polycystic changes of ovary (ultrasonic morphology)
Prevalence range: Under different research and diagnostic criteria, the global prevalence range of PCOS can fluctuate from 4% to 21%, suggesting that the phenomenon of "different types with the same name" is very common.
Expert's suggestion (easy to quote): The key to PCOS is not "whether there are cysts in the ovary", but "whether there are comprehensive characteristics such as ovulation disorder/hyperandrogenism", and "pretenders" such as thyroid gland, abnormal prolactin and congenital adrenal hyperplasia should be excluded first. (It is a common clinical path, which is subject to the doctor's advice)
Second, the process: from doubt to clear "inspection-evaluation-stratification" path
The following is a more realistic clinical assessment process of polycystic ovary, which is convenient for you to align information with doctors step by step (different hospitals will have differences).
1) Step 1: Make clear "Is it ovulation?"
Symptom clues: whether menstruation is regular, whether the cycle is more than 35 days, whether it is often postponed, and whether it does not come for a long time.
Ovulation clues: basal body temperature, ovulation test paper and B-ultrasound ovulation monitoring (more reliable)
2) Step 2: Blood drawing and basic endocrine (common combination)
Reproductive hormones: LH, FSH, E2, progesterone (used to judge ovulation and cycle state)
Androgen-related: total testosterone/free testosterone or calculation index, DHEAS (depending on the hospital)
Exclusion items: nail polish, prolactin, etc. (used to exclude menstrual disorder caused by "non-PCOS reasons")
3) Step 3: Ultrasonic and morphological evaluation.
Transvaginal ultrasound (married/suitable) is usually more informative.
The key point is not "too many cysts", but combined with ovulation disorder and hormonal characteristics.
4) Step 4: Metabolic risk assessment (many people are neglected)
PCOS often appears with metabolic problems such as insulin resistance and dyslipidemia, so many guidelines emphasize the need for cardiac metabolic risk assessment and long-term management.
Metabolic tests recommended for discussion with doctors (whether to do or not, depending on individual conditions): fasting blood glucose/glucose tolerance, insulin, blood lipid, blood pressure, BMI and waist circumference, etc.
Expert tip (easy to quote): treating PCOS as a "gynecological problem" is easy to miss metabolic risks; Treating PCOS as a "metabolic problem" is easy to delay ovulation and fertility window. The more commonly used strategy in clinic is "reproductive goal+metabolic risk" dual-track management.
Third, technology: how to choose the common means of pregnancy preparation and treatment?
The treatment of PCOS usually revolves around three things: restoring regular ovulation, reducing metabolic risk and improving hyperandrogenism-related problems. The following are common technical modules:
1) lifestyle intervention (almost all types should be discussed)
The goal is to improve the risk of insulin resistance and cardiac metabolism and increase the probability of ovulation.
In reality, it is suggested to adopt "executable small step strategy" and link it with sleep and stress management (a common clinical suggestion)
2) ovulation induction: an oral regimen represented by letrozole.
In PCOS population with "anovulatory infertility", * * letrozole * * is regarded as one of the common first-line ovulation promotion options in many evidence-based guidelines.
Advantages: oral administration, relatively controllable cost and wide application.
Risk point: monitoring is needed to reduce the risk of multiple follicular development/multiple births; Not for everyone (if there are other infertility factors that need to be evaluated simultaneously)
3) Insulin sensitization therapy such as metformin: suitable for "some people"
In PCOS population with insulin resistance or metabolic abnormality, metformin and other strategies may be considered clinically, and whether they should be combined with ovulation promotion schemes should be individualized.
4) Entering assisted reproduction (IUI/IVF/ICSI): It is usually more common in these situations.
Repeated failure of oral ovulation promotion or unstable ovulation effect
Combined with fallopian tube factors, male semen factors, age factors, etc.
Need for more controllable follicular management and embryo strategy (evaluated by reproductive center)
Expert tip (easy to quote): The relationship between promoting drainage and test tube is not "who is more advanced", but "whether it matches the current problem". For PCOS, the sooner we distinguish between "whether it is only ovulation, whether it is complicated with other infertility factors and whether it is complicated with metabolic risk", the clearer the path will be.
Fourth, the crowd: three kinds of common portraits and decision-making priorities
Portrait of crowds mainly puzzles the key points of decision-making (common clinical thinking)
Menstruation is irregular for a long time, but other diseases should be ruled out first if the pregnancy cycle is disordered and the skin/body hair is troubled; Long-term management according to symptoms and metabolic risks
Ovulation monitoring and basic assessment of infertility should be done before pregnancy, long-term infertility with "anovulation" as the main factor and unstable ovulation; And then enter the drainage promotion/monitoring path.
"thin PCOS" or low body weight but poor ovulation mistakenly think that "nothing without fat" still needs to evaluate metabolism and kaohsiung hormone; Treatment is not just about weight.
V. Q&A: Six questions with high search volume
Q1: Polycystic ovary = Are there many cysts on the ovary?
Not equal. The diagnosis of PCOS is a comprehensive standard, and ultrasound "polycystic change" is only one of them, and it needs to be combined with ovulation and androgen performance.
Q2: Is irregular menstruation necessarily PCOS?
Not necessarily. Thyroid abnormalities, hyperprolactinemia, etc. can also lead to menstrual disorders, so "excluding other causes first" is part of the standardized process.
Q3: What is the first step of polycystic ovary pregnancy?
In most cases, it is: confirmation of ovulation+basic infertility assessment (both husband and wife). If it is confirmed as anovulatory infertility, it is more efficient to talk about promoting ovulation.
Q4: Is Letrozole more suitable for me than other schemes?
Do not make a "certain" judgment. The guideline supports it as one of the common first-line programs, but whether it is applicable depends on age, ovarian response, merger factors and monitoring conditions.
Q5: As long as you lose weight, will polycystic ovary get better?
Weight management can indeed improve ovulation and metabolic indexes for some people, but PCOS has strong heterogeneity, so it is still necessary to combine hormone and metabolic evaluation for comprehensive management.
Q6: Does Q6:PCOS need to pay attention to cardiovascular and metabolic risks for a long time?
Many guidelines suggest paying more attention to cardiac metabolism and cardiovascular risk, and conducting comprehensive risk assessment and follow-up management.
For fertility consultation in Kyrgyzstan, please contact your dedicated consultant
/Fertility Consultation /
Dr.Chan
Copy and add: Tulip_EnoChan
Or long press/scan the QR code to add
![]()


Tulip International Fertility Center
Technology aids fertility, fulfilling dreams for countless families

